BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 25762141)

  • 1. Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.
    Mitchell DA; Batich KA; Gunn MD; Huang MN; Sanchez-Perez L; Nair SK; Congdon KL; Reap EA; Archer GE; Desjardins A; Friedman AH; Friedman HS; Herndon JE; Coan A; McLendon RE; Reardon DA; Vredenburgh JJ; Bigner DD; Sampson JH
    Nature; 2015 Mar; 519(7543):366-9. PubMed ID: 25762141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetanus shot may improve glioblastoma treatment.
    Cancer Discov; 2015 Jun; 5(6):571. PubMed ID: 25877510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer immunotherapy: dendritic-cell vaccines on the move.
    Sabado RL; Bhardwaj N
    Nature; 2015 Mar; 519(7543):300-1. PubMed ID: 25762139
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy: Primed for a response.
    Seton-Rogers S
    Nat Rev Cancer; 2015 May; 15(5):258-9. PubMed ID: 25833215
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer immunotherapy: Primed for a response.
    Seton-Rogers S
    Nat Rev Drug Discov; 2015 May; 14(5):312. PubMed ID: 25907340
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
    J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells cross-talk with tumour antigen-specific CD8
    Eiraku Y; Terunuma H; Yagi M; Deng X; Nicol AJ; Nieda M
    Clin Exp Immunol; 2018 Oct; 194(1):54-66. PubMed ID: 30009488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.
    Nair SK; De Leon G; Boczkowski D; Schmittling R; Xie W; Staats J; Liu R; Johnson LA; Weinhold K; Archer GE; Sampson JH; Mitchell DA
    Clin Cancer Res; 2014 May; 20(10):2684-94. PubMed ID: 24658154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.
    Hong S; Li H; Qian J; Yang J; Lu Y; Yi Q
    Clin Exp Immunol; 2012 Nov; 170(2):167-77. PubMed ID: 23039887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment.
    Liu KJ; Chao TY; Chang JY; Cheng AL; Ch'ang HJ; Kao WY; Wu YC; Yu WL; Chung TR; Whang-Peng J
    J Biomed Sci; 2016 Aug; 23(1):64. PubMed ID: 27558635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.
    Reap EA; Suryadevara CM; Batich KA; Sanchez-Perez L; Archer GE; Schmittling RJ; Norberg PK; Herndon JE; Healy P; Congdon KL; Gedeon PC; Campbell OC; Swartz AM; Riccione KA; Yi JS; Hossain-Ibrahim MK; Saraswathula A; Nair SK; Dunn-Pirio AM; Broome TM; Weinhold KJ; Desjardins A; Vlahovic G; McLendon RE; Friedman AH; Friedman HS; Bigner DD; Fecci PE; Mitchell DA; Sampson JH
    Cancer Res; 2018 Jan; 78(1):256-264. PubMed ID: 29093005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients.
    Wang QT; Nie Y; Sun SN; Lin T; Han RJ; Jiang J; Li Z; Li JQ; Xiao YP; Fan YY; Yuan XH; Zhang H; Zhao BB; Zeng M; Li SY; Liao HX; Zhang J; He YW
    Cancer Immunol Immunother; 2020 Jul; 69(7):1375-1387. PubMed ID: 32078016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.
    Batich KA; Reap EA; Archer GE; Sanchez-Perez L; Nair SK; Schmittling RJ; Norberg P; Xie W; Herndon JE; Healy P; McLendon RE; Friedman AH; Friedman HS; Bigner D; Vlahovic G; Mitchell DA; Sampson JH
    Clin Cancer Res; 2017 Apr; 23(8):1898-1909. PubMed ID: 28411277
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report.
    Liau LM; Black KL; Martin NA; Sykes SN; Bronstein JM; Jouben-Steele L; Mischel PS; Belldegrun A; Cloughesy TF
    Neurosurg Focus; 2000 Dec; 9(6):e8. PubMed ID: 16817691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling.
    Dastmalchi F; Karachi A; Yang C; Azari H; Sayour EJ; Dechkovskaia A; Vlasak AL; Saia ME; Lovaton RE; Mitchell DA; Rahman M
    J Immunother Cancer; 2019 Nov; 7(1):321. PubMed ID: 31753028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma cell lysate induces CCR7 expression and in vivo migration to draining lymph nodes of therapeutic human dendritic cells.
    González FE; Ortiz C; Reyes M; Dutzan N; Patel V; Pereda C; Gleisner MA; López MN; Gutkind JS; Salazar-Onfray F
    Immunology; 2014 Jul; 142(3):396-405. PubMed ID: 24673602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL3 and CCL20-recruited dendritic cells modified by melanoma antigen gene-1 induce anti-tumor immunity against gastric cancer ex vivo and in vivo.
    He S; Wang L; Wu Y; Li D; Zhang Y
    J Exp Clin Cancer Res; 2010 Apr; 29(1):37. PubMed ID: 20420712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant effect of a natural TLR4 ligand on dendritic cell-based cancer immunotherapy.
    Kim JY; Kim YJ; Kim JS; Ryu HS; Lee HK; Kang JS; Kim HM; Hong JT; Kim Y; Han SB
    Cancer Lett; 2011 Dec; 313(2):226-34. PubMed ID: 21974804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safe and Reproducible Preparation of Functional Dendritic Cells for Immunotherapy in Glioblastoma Patients.
    Nava S; Lisini D; Pogliani S; Dossena M; Bersano A; Pellegatta S; Parati E; Finocchiaro G; Frigerio S
    Stem Cells Transl Med; 2015 Oct; 4(10):1164-72. PubMed ID: 26273063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of dendritic cell vaccine-based immunotherapies for glioblastoma.
    Reardon DA; Mitchell DA
    Semin Immunopathol; 2017 Feb; 39(2):225-239. PubMed ID: 28138787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.